67600-79-7Relevant articles and documents
Histamine H3 Inverse Agonists and Antagonists and Methods of Use Thereof
-
, (2011/04/18)
Provided herein are fused imidazolyl compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, including, e.g., neurological disorders and metabolic disorders. Compounds provided herein inhibit the activity of histamine H3 receptors and modulate the release of various neurotransmitters, such as, e.g., histamine, acetylcholine, norepinephrine, and dopamine (e.g. at the synapse). Pharmaceutical compositions containing the compounds and their methods of use are also provided herein.
Preparation of new monomers aza-β3-aminoacids for solid-phase syntheses of aza-β3-peptides
Busnel, Olivier,Baudy-Floc'h, Miche?le
, p. 5767 - 5770 (2008/02/09)
The preparation of new Nβ-Fmoc-protected aza-β3-amino acids (aza-β3-aa) with proteinogenic side chains as well as their Nβ-Fmoc, Nβ-Cbz or Nβ-Boc aza-β3-amino esters (from Pro, Asn, Asp, Glu, Gln) by successive nucleophilic substitutions will be described.
Facile scalable reduction of N-acylated dihydropyrazoles
Curtis, Michael D.,Hayes, Nancy C.,Matson, Patricia A.
, p. 5035 - 5038 (2007/10/03)
The reduction of a variety of highly functionalized N-acylated dihydropyrazoles (1) with BH3-pyridine is described. The process through which this unexpectedly difficult reduction was discovered and developed is reported. A facile atom-efficien